home / stock / vvos / vvos news


VVOS News and Press, Vivos Therapeutics Inc. From 10/24/23

Stock Information

Company Name: Vivos Therapeutics Inc.
Stock Symbol: VVOS
Market: NASDAQ
Website: vivoslife.com

Menu

VVOS VVOS Quote VVOS Short VVOS News VVOS Articles VVOS Message Board
Get VVOS Alerts

News, Short Squeeze, Breakout and More Instantly...

VVOS - Vivos Therapeutics, Lincare ink distribution deal

2023-10-24 09:17:29 ET Medical technology firm Vivos Therapeutics ( NASDAQ: VVOS ) has entered into a U.S. nationwide distribution deal with in-home respiratory therapy products supplier, Lincare. Under the deal, Lincare will have a six-month exclusivity to distribute cert...

VVOS - Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

LITTLETON, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS a leading medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (O...

VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) New Middle East-North Africa Distribution Deal Spotlighted in Proactive Interview

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing-related sleep conditions arising from cert...

VVOS - Vivos Therapeutics secures Middle East-North Africa distribution deal and Stanford study

--News Direct-- Vivos Therapeutics CEO Kirk Huntsman joined Steve Darling from Proactive to share an exciting development for the company. Vivos has just entered into an exclusive distribution agreement with NOUM DMCC, a Dubai-based company with a strong focus on diagnostic testing an...

VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Launch of DNA Clinical Trial

Vivos Therapeutics (NASDAQ: VVOS) is a medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The company today announced that its flagship daytime-nighttime applianc...

VVOS - Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

LITTLETON, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company") (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (OSA) and snor...

VVOS - 24/7 Market News Wrap for 6 Oct 2023

2023-10-06 15:43:10 ET DENVER, Colo., Oct 6, 2023 ( www.247marketnews.com )- The following companies were among the listings that we covered this week; IceCure Medical Ltd. (NASDAQ: ICCM), Femasys (NASDAQ: FEMY), SeaStar Medical Holding (NASDAQ: ICU), Siyata Mobile (NASDAQ: SYTA), Vivos...

VVOS - 24/7 Market News Snapshot 5 Oct 2023

2023-10-05 10:10:30 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; IceCure Medical Ltd. (NASDAQ: ICCM), VS Media Holdings (NASDAQ: VSME), Vivos Therapeutics (NASDAQ: VVOS), Femas...

VVOS - Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing Company Subject to Regulatory Approvals, Vivos Could See Revenue From This Collaboration in 2024 LITTLETON, Colo., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the “Company...

VVOS - Creating a Profitable Penny Stocks Watchlist

2023-10-05 06:59:00 ET 3 Tips for Creating a Profitable Penny Stocks Watchlist Penny stocks offer a unique opportunity for investors looking to diversify their portfolios and potentially achieve substantial returns. These stocks, typically priced under $5, have the potential to provide ...

Previous 10 Next 10